Variability in Cyclicity Affects Pain and Other Symptoms In Female Fibromyalgia Syndrome Patients

REFERENCES

• Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fichtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russel I J, Sheon R P. The American College of Rheumatology 1990 Criteria for the classification of Fibromyalgia. Arthritis Rheum 1990; 33: 160–172
   PubMed Web of Science ®Google Scholar
• Wolfe F, Ross K, Andersson J, Russel I J, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995; 38: 19–28
   PubMed Web of Science ®Google Scholar
• Waxman J, McSherry Zatkis S. Fibromyalgia and menopaus. Postgraduate Medicine 1986; 80(4)165–171
   PubMed Web of Science ®Google Scholar
• Bäckström T, Baird D T, Bancroft J, Bixo M, Hammarbäck S, Sanders D, Smith S, Zetterlund B. Endocrinological aspects of cyclical mood changes during the menstrual cycle or the premenstrual syndrome. J Psychosom Obstet Gynaecol 1983; 2: 8–20
   Google Scholar
• Halbreich U. Gonadal hormones and antihormones, serotonin and mood. Psychopharm Bull 1990; 26: 291–295
   PubMedGoogle Scholar
• Guicheney P, Marcel D. Decrease of platelet serotonin content in ovariectomized female rats. Endocrinology 1984; 111(6)2412–2414
   Google Scholar
• Biegon A, Fischette C T, Rainbow T C, McEwen B S. Serotonin receptor modulation by estrogen in discrete brain nuclei. Neuroendocrinology 1982; 35: 287–291
   PubMed Web of Science ®Google Scholar
• Kendall D, Stancel G M, Enna S J. Imipramlne: Effect of ovarian steroids on modifications in serotonin receptor binding. Science 1981; 211: 1183–1185
   PubMed Web of Science ®Google Scholar
• Rehavi M, Sepcuti H, Weizman A. Upregulation by imipramin binding and serotonin uptake by estradiol in female rat brain. Brain Research 1987; 410: 135–139
   PubMed Web of Science ®Google Scholar
• Crowley W R, O'Donohue T L, Muth E A, Jacobowitz D M. Effects of ovarian hormones on levels of luteinizing hormone in plasma and on serotonin concentrations in discrete brain nuclei. Brain Research Bulletin 1979; 4: 571–574
   PubMed Web of Science ®Google Scholar
• Cone R I, Davis G A, Goy R W. Effects of ovarian steroids on serotonin metabolism within grossly dissected and microdissected brain regions of the ovariectomized rat. Brain Research Bulletin 1981; 7: 639–644
   PubMed Web of Science ®Google Scholar
• Rapkin A J, Shoupe D, Reading A, Daneshgar K K, Goldman L, Bohn Y, Brann D W, Mahesh V B. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone. J Soc Gynecol Invest 1996; 3(2)93–98
   PubMedGoogle Scholar
• Shoupe D, Montz F J, Lobo R A. The effects of estrogen and progestin on endogenous opioid activity in oophorectomized women. J Clin Endocrinol Metab. 1985; 60: 178–183
   PubMed Web of Science ®Google Scholar
• Wardlaw S L, Wehrenberg W B, Ferin M, Antunes J L, Frantz A G. Effect of sex steroids on B-endorphin in hypophyseal portal blood. J Clin Endocrinol Metab 1982; 55: 877–888
   PubMed Web of Science ®Google Scholar
• Chrousos G P, Gold P W. The concepts of stress and stress system disorders. JAMA 1992; 267(9)1244–1252
   PubMed Web of Science ®Google Scholar
• Vamkopoulus N C, Chrousos G P. Evidence of direct extrogenic of human corticotropin-releasing hormone gene expression: J Clin Invest 1993; 92(4)1896–1902
   Google Scholar
• Young E A. The role of gonadal steroids in hypothalamic-pituitary-adrenal axis regulation. Critical Reviews in Neurobiol 1995; 9(4)371–381
   PubMedGoogle Scholar
• Russel I J. Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis Clin N Am 1989; 15: 149–168
   PubMed Web of Science ®Google Scholar
• Russel I J, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992; 35(5)550–556
   PubMedGoogle Scholar
• Russel I J. Neurohormonal: Abnormal laboratory findings related to pain and fatigue in fibromyalgia. J Musculoske Pain 1995; 3(2)59–65
   Google Scholar
• Vaeroy H, Helle R, Forre O, et al. Elevated CSF levels of substance P and high incidence of Raynaud's phenomen in patients with fibromyalgia: new features for diagnosis. Pain 1988; 32: 21–26
   PubMed Web of Science ®Google Scholar
• Vaeroy H, Nyberg F, Terenius L. No evidence for endorphin deficiency following investigation of cerebrospinal fluid (CSF) dynorphin A and met-enkephalin-Arg6-Phe7. Pain 1991; 46(2)139–143
   PubMed Web of Science ®Google Scholar
• Crofford L J, Pillemer S R, Kalogeras K T, Cash J M, Michelson D, Kling M A, Sternberg E M, Gold P W, Chrousos G P, Wilder R L. Hypothalamic-pituitary-adrenal axis in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583–1592
   PubMed Web of Science ®Google Scholar
• Griep E N, Boersma J W, de Koet E R. Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheum 1993; 20(3)474
   Web of Science ®Google Scholar
• Sundblad C, Wikander I, Andersch B, Eriksson E. A naturalistic study of Paroxetin in premenstrual syndrome: efficacy and side effects during ten cycles of treatment. thesis: Serotonin, Androgens and Behaviour. Department of Pharmacology, University of Gothenburg. 1996
   Google Scholar
• Aloisi A M, Albonetti M E, Sacerdote P, Carli G. Sex dependent effects of stress and pain on choline acetyltransferase activity levels and B-endorphin content in discrete areas of the rat brain. The brain: source and target for sex steroid hormones. 1st Tuscania conference on reproductive medicine., A R Genazzani, F Petralgia. University of Pisa, Italy, and RH Purdy, University of California, USA. The Pantheon Publishing Group, 1996, pp. 431–439
   Google Scholar
• Kavaliers M, Galea L AM. Sex differences in the expression of swim stress-induced analgesia in deer mice vary with the breading season. Pain 1995; 63: 327–334
   PubMed Web of Science ®Google Scholar
• Amundusson Å, Hermansson O, Blomqvist A. Estrogen receptor-like immumoreactivity in the medullary and spinal dorsal horn of the female rat. Neuroscience Letters 1995; 196: 25–28
   PubMed Web of Science ®Google Scholar
• Amundusson Å, Hermansson O, Blomqvist A. Colocalization oestrogen receptor immunoreactivity and preproenkephalin mRNA expression to neurons in the superficial laminae of the spinal and dorsal horn of rats. European Journal of Neuroscience 1996; 8: 2440–2445
   PubMed Web of Science ®Google Scholar
• Wolfe F, Ross K, Andeson J, Russel I J. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 1995; 21(1)151–156
   Google Scholar
• Della Corte M, Procacci P, Bozza G, Buzzelli G. A study on the cutaneous pricking pain threshold in normal man. Arch Fisiol 1965; 64: 141–170
   Google Scholar
• von Knorring L, Espvall M, Ferris C. Averaged evoked responses, pain measures, and personality variables in patients with depressive disorders. Acta Psychiatr Scand Suppl 1974; 255: 99–108
   PubMedGoogle Scholar
• von Knorring L. An experimental study of visual averaged evoked responses and pain measures in patients with depressive disorders. Biol Psychol 1978; 6(1)27–38
   PubMed Web of Science ®Google Scholar
• Goolkasian P. Cyclic changes in pain perception: an ROC analysis. Perception and Psychophysics 1980; 27(6)499–504
   PubMedGoogle Scholar
• Herren R Y. The effect of high and low female sex hormone concentration on the two-point threshold of pain and touch and upon tactile sensitivity. J Exp Psychol 1933; 16: 324–327
   Google Scholar
• Veith J L, Anderson J, Slade S A, Thompson P, Laugel G R, Getzlaf S. Plasma B-endorphin, pain thresholds and anxiety levels across the human menstrual cycle. Physiology and Behavior 1984; 32: 31–35
   PubMed Web of Science ®Google Scholar
• The Diagnostic and Statistical Manual of Mental Disorders, 3rd edition. American Psychiatric Association, Washington, DC 20005, revised. USA
   Google Scholar
• Hammarbäck S, Bäckström T, MacGibbon-Taylor B. Diagnosis of premenstrual tension syndrome: description and evaluation of a procedure for diagnosis and differential diagnosis. J Psychosom Obstet Gynaecol 1989; 10: 25–42
   Web of Science ®Google Scholar
• The Diagnostic and Statistical Manual of Mental Disorders, 4th edition. American Psychiatric Association, Washington, DC 20005; 715–718, USA1994
   Google Scholar
• Spitzer R, Williams J BW, Gibbon M. Stuctural Clinical Interview for DSM-111-R-Patient Version (SCID-P, 6/1/81). 1997, Bioresearch
   Google Scholar
• Hallman J. The premenstrual syndrome-an equivalent of depression?. Acta Psychiatr Scand 1986; 73: 403–411
   PubMed Web of Science ®Google Scholar
• Anderscti B. Epidemiological, hormonal and water balance studies in premensstrual tension. Department of Gynecology and Psychiatry, University of Gothenburg, Sweden 1980, Thesis
   Google Scholar
• von Knorring L. Depression. Nord Med 1996; 111: 259–263
   PubMedGoogle Scholar
• Sartorius N. Depressive illness as a worldwide problem. Depression in every day pratice. Bern/Stuttgart/Vienna, P Kielholz. Hans Huber Publ. 1974; 18–24
   Google Scholar
• Ferin M, Van Vugt D, Wardlaw S. The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. Recent Prog Horm Res 1984; 40: 441–445
   PubMedGoogle Scholar
• Vrbicky K W, Baumstark J S, Wells I C, Hilgers T W, Kable W T, Elias C J. Evidence for the involvement of B-endorphin in the human menstrual cycle. Fertility and Sterility 1982; 38(6)701–704
   PubMed Web of Science ®Google Scholar
• Wehrenberg W B, Wardlaw S L, Frantz A G, Ferin M. B-endorphin in hypophyseal portal blood: variations throughout the menstrual cycle. Endocrinology 1982; 3: 879–881
   Google Scholar
• von Knorring L, Perris C, Eisemann M, Eriksson U, Penis H. Pain as a symptom in depressive disorders. I. Relationship to a diagnostic subgroup and depressive symptomatology. Pain 1983; 15: 19–26
   Web of Science ®Google Scholar
• von Knorring L, Ekselius L. Idiopathic pain and depresion: Quality of life research 1994; 3: 57–68
   Web of Science ®Google Scholar
• Bäckström T. Neuroendocrinology of premenstrual syndrome: Clin Obstet Gynaecol 1992; 35(3)612–628
   Google Scholar
• Sundström I, Ashbrook D, Bäckström T. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study: Psychoneuroendocrinology 1997; 22(1)25–38
   Google Scholar
• Schmidt P J, Nieman L K, Danaceau M A, Adams L F, Rubinow D R. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998; 338(4)209–216
   PubMed Web of Science ®Google Scholar
• Nörregard J, Volkmann H, Danneskiold-Samoe B. A randomized controlled trial of Citalopram in the treatment of fibromyalgia. Pain 1995; 61: 445–449
   PubMed Web of Science ®Google Scholar
• Eriksson E, Hedberg M A, Andersch B, Sundblad C. The serotonin reuptake inhibitor Paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 1995; 12(2)167–176
   PubMed Web of Science ®Google Scholar
• Ashby C R, Carr L A, Cook C L, Steptoe M M, Franks D D. Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome. J Neural Transm (Gen-Sect) 1990; 79: 41–50
   PubMed Web of Science ®Google Scholar
• Blum I, Nessiel L, David A, Graff E, Harsat A, Weissglas L, Gabbay U, Sulke S J, Yerushalmy Y, Vered Y. Plasma neurotransmitter profile during different phases of the ovulatory cycle. J Clin Endocrinol Metabol 1992; 75: 924–929
   PubMed Web of Science ®Google Scholar
• Crofford L J. The Hypothalamic-Pituitary-Adrenal Stress Axis in the Fibromyalgia syndrome. J Musculoske Pain 1996; 4(1/2)181–200
   Google Scholar
• Genazzani A R, Lemarchand-Beraud T, Aubert M L, Felber J P. Pattern of plasma ACTH, hGH, and Cortisol during the menstrual cycle. Endocrinol Metabol 1975; 41(3)431–437
   PubMedGoogle Scholar